InCerebro (Drug Discovery) is Drug Discovery in South Korea that focus on cancer metastasis inhibitors business. Founded in 2019. They cover business area such as operator, new drug, computing-base research, molecular modeling, AI technology, anti-cancer agent, cancer metastasis inhibitor, immunotherapy, skin treatment, medical treatment.
2019
( 5 years old in 2024 )
Cancer Metastasis Inhibitors
-
Room 704, Seoul Technopark
232 Gongneung-ro, Nowon-gu
Seoul, 01811
South Korea
Private
operatornew drugcomputing-base researchmolecular modelingAI technologyanti-cancer agentcancer metastasis inhibitorimmunotherapyskin treatmentmedical treatment
* We use standard office opening hours in near InCerebro (Drug Discovery)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
InCerebro (Drug Discovery) is Drug Discovery business from South Korea that founded in 2019 (5 years old in 2024), InCerebro (Drug Discovery) business is focusing on Cancer Metastasis Inhibitors.
InCerebro (Drug Discovery) headquarter office and corporate office address is located in Room 704, Seoul Technopark 232 Gongneung-ro, Nowon-gu Seoul, 01811 South Korea.
InCerebro (Drug Discovery) was founded in South Korea.
In 2024, InCerebro (Drug Discovery) is currently focus on cancer metastasis inhibitors sector.
Above is snippet of Google Trends for "cancer metastasis inhibitors" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with InCerebro (Drug Discovery), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
